Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Identification of an ATP/P2X7/mast cell pathway mediating ozone-induced bronchial hyperresponsiveness
Xiaomei Kong, … , Samir N.P. Kelada, Stephen L. Tilley
Xiaomei Kong, … , Samir N.P. Kelada, Stephen L. Tilley
Published September 21, 2021
Citation Information: JCI Insight. 2021;6(21):e140207. https://doi.org/10.1172/jci.insight.140207.
View: Text | PDF
Research Article Cell biology Immunology

Identification of an ATP/P2X7/mast cell pathway mediating ozone-induced bronchial hyperresponsiveness

  • Text
  • PDF
Abstract

Ozone is a highly reactive environmental pollutant with well-recognized adverse effects on lung health. Bronchial hyperresponsiveness (BHR) is one consequence of ozone exposure, particularly for individuals with underlying lung disease. Our data demonstrated that ozone induced substantial ATP release from human airway epithelia in vitro and into the airways of mice in vivo and that ATP served as a potent inducer of mast cell degranulation and BHR, acting through P2X7 receptors on mast cells. Both mast cell–deficient and P2X7 receptor–deficient (P2X7–/–) mice demonstrated markedly attenuated BHR to ozone. Reconstitution of mast cell–deficient mice with WT mast cells and P2X7–/– mast cells restored ozone-induced BHR. Despite equal numbers of mast cells in reconstituted mouse lungs, mice reconstituted with P2X7–/– mast cells demonstrated significantly less robust BHR than mice reconstituted with WT mast cells. These results support a model where P2X7 on mast cells and other cell types contribute to ozone-induced BHR.

Authors

Xiaomei Kong, William C. Bennett, Corey M. Jania, Kelly D. Chason, Zachary German, Jennifer Adouli, Samuel D. Budney, Brandon T. Oby, Catharina van Heusden, Eduardo R. Lazarowski, Ilona Jaspers, Scott H. Randell, Barry A. Hedgespeth, Glenn Cruse, Xiaoyang Hua, Stephen A. Schworer, Gregory J. Smith, Samir N.P. Kelada, Stephen L. Tilley

×

Figure 1

Ozone increases resistance in the murine lung and induces marked BHR in response to methacholine.

Options: View larger image (or click on image) Download as PowerPoint
Ozone increases resistance in the murine lung and induces marked BHR in ...
C57BL/6 WT mice (females, aged 8–40 weeks) were exposed to 2 ppm ozone or air for 3 hours, and airway mechanics at baseline and to graded methacholine challenges were measured 24 hours later for (A) total lung resistance (RL), (B) peripheral airway resistance (G), (C) central airway resistance (Raw), (D) methacholine challenge, (E) static lung compliance (Cst), and (F) dynamic lung compliance (Cdyn). Yellow circles represent air-treated mice (n = 13), and blue circles represent ozone-treated mice (n = 61); *P < 0.05 by Student’s t test (A and B) and mixed effects analysis comparing repeated measures between air and ozone (*P < 0.05) (D). Ozone exposure has no effect on static or dynamic lung compliance (E and F). Data are shown as mean ± SEM.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts